The Big Picture
GLP-1s and the New Era of Medical Weight Loss
GLP-1s define the new era of medical weight loss: GLP-1 receptor agonists, semaglutide and tirzepatide, are the weight-loss medications with the strongest trial evidence. They act on the body's own appetite and blood-sugar signaling. They are prescription drugs with real side effects, and they work best inside a supervised program built on labs, monitoring and a long-term plan.
This guide walks through the science in plain language: what GLP-1s are, how they work, who tends to be a good candidate, what the safety picture looks like, and what thoughtful, physician-led care involves. Protocol Health sees patients in person at our Scarsdale clinic and by telehealth across New York, New Jersey, Connecticut, Florida and California.
Explore Our Medical Weight Loss ProgramQuick Answer
What are GLP-1 medications for weight loss?
GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that mimic a natural gut hormone your body releases after eating. They help regulate appetite, slow how quickly the stomach empties, and support healthier blood-sugar signaling. For many people the practical result is reduced hunger, earlier fullness, and fewer cravings, which can make a meaningful calorie reduction feel more sustainable.
The most widely used options are semaglutide (a GLP-1 agonist) and tirzepatide (which acts on both GLP-1 and GIP receptors). Both should be used under medical supervision, with dosing individualized to the patient. Research suggests they can support significant weight loss in many patients when combined with nutrition and lifestyle change, though individual results vary and are never guaranteed. This guide covers the GLP-1 class as a whole; for semaglutide alone in depth, see semaglutide for weight loss, and for how GLP-1s compare with the other peptides marketed for weight loss, see the best peptides for weight loss.
The Science
How do GLP-1s actually work in the body?
GLP-1s work in the body by amplifying GLP-1, a hormone your intestines release when you eat that signals the pancreas, the brain, and the digestive tract. GLP-1 medications extend and amplify that natural signal. In the brain's appetite centers, they can turn down hunger and the reward-driven urge to eat. In the stomach, they slow gastric emptying, so you may feel full longer on less food.
Tirzepatide adds a second mechanism by also engaging the GIP receptor, another gut-hormone pathway involved in metabolism and appetite regulation. This dual action is part of why it has drawn so much clinical attention.
Importantly, these medications work with your biology, not around it. They don't dissolve fat or replace the need for good nutrition and movement. What they can do is quiet the persistent hunger and food-preoccupation that make sustained change so difficult, creating room for healthier habits to take hold.
Trial Results
How much weight do people lose on GLP-1s?
People on GLP-1s lose an average in the mid-teens of their body weight, based on the large trials run over about a year and a half. In the STEP 1 trial, 1,961 adults with overweight or obesity and without diabetes took semaglutide 2.4 mg weekly or placebo for 68 weeks, alongside a lifestyle program. The semaglutide group lost an average of 14.9% of body weight, compared with 2.4% on placebo, and about half lost 15% or more.
In the SURMOUNT-1 trial, 2,539 adults with obesity took tirzepatide or placebo for 72 weeks. Average weight loss was 15.0%, 19.5% and 20.9% on the 5 mg, 10 mg and 15 mg doses, versus 3.1% on placebo.
Two cautions belong next to those numbers. They are averages: some participants lost far more and some far less. And they come from trials of the FDA-approved brand-name medications given with lifestyle support, so they describe what the drugs can do under trial conditions, not a promise for any one person.
Which Is Best
Which GLP-1 is best for weight loss?
The best GLP-1 for weight loss in the only large head-to-head trial so far was tirzepatide, which produced more weight loss than semaglutide. The SURMOUNT-5 trial randomized 751 adults with obesity but without type 2 diabetes to the highest tolerated weekly dose of either drug for 72 weeks. Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide, and waist circumference fell more with tirzepatide too. The trial was open-label and funded by Eli Lilly, which makes tirzepatide.
That does not make tirzepatide the best GLP-1 for every person. The right medication depends on your medical history, other conditions such as type 2 diabetes or heart disease, and how you tolerate side effects. Some people do well on semaglutide and have no reason to switch; others who plateau on one may respond to the other.
At Protocol Health, the choice between semaglutide and tirzepatide is made with your physician after a consultation and labs, not from a ranking.
Dosage
GLP-1 dosage for weight loss: how titration works
GLP-1 medications for weight loss start at a low dose and step up gradually. The slow climb gives the gut time to adjust and is the main way clinicians keep nausea and other side effects manageable.
In the semaglutide trials, participants escalated over about 16 weeks to a maintenance dose of 2.4 mg once weekly. In SURMOUNT-1, tirzepatide maintenance doses of 5 mg, 10 mg and 15 mg once weekly were studied. Those are the doses the research used, not a schedule to follow on your own.
Your prescribing physician sets your starting dose, how fast it rises and where it stops, based on your response, side effects, goals and labs. Some people reach their goal on a lower dose and never need the top of the range. Changing your dose without your prescriber is one of the most common reasons people end up with avoidable side effects.
Beyond the Scale
What benefits do GLP-1s offer besides weight loss?
GLP-1s offer benefits besides weight loss, including better blood-sugar control and improved cardiometabolic risk factors. The most visible benefit is weight reduction, but the metabolic story is often broader. GLP-1 therapy improves blood-sugar control, which is why this drug class was first developed for type 2 diabetes. In STEP 1, people on semaglutide also had greater improvements in cardiometabolic risk factors than people on placebo.
The strongest outcome evidence is the SELECT trial, covered below, in which semaglutide lowered the rate of heart attack, stroke and cardiovascular death in people with existing heart disease. These are population-level results, not promises for any one person, and they are best interpreted by your physician alongside your own labs and history.
For patients focused on the bigger picture, weight and metabolic health connect directly to longevity and preventive care. Explore our approach to metabolic and cardiovascular health and longevity and preventive health.
Candidacy
Who is a good candidate for GLP-1 therapy?
A good candidate for GLP-1 therapy is generally an adult working toward meaningful weight loss, often with an elevated body mass index or weight-related metabolic concerns, who has found lifestyle changes alone insufficient. Candidacy is always determined case by case by a physician, not by a number on a chart.
In the major trials, participants generally had a body mass index of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure or prediabetes. Those trial criteria are a useful reference point, but they are not the whole decision.
Some people are not appropriate candidates. A personal or family history of certain thyroid cancers, a history of pancreatitis, pregnancy or planning pregnancy, and specific gastrointestinal conditions are among the factors that can make these medications unsuitable. This is exactly why a real medical evaluation, not a quick online questionnaire, matters.
At Protocol Health, candidacy is grounded in a consultation and, where appropriate, laboratory work. Protocol Health's medical weight loss program is designed to match the right approach, whether that's semaglutide, tirzepatide, or another path, to the right patient.
Safety First
What are the side effects and safety considerations?
The most common side effects are gastrointestinal: nausea, constipation, diarrhea, and reflux, particularly in the early weeks or after a dose increase. For many patients these effects are mild and ease over time, and careful, gradual dose titration is one of the main reasons medical supervision matters so much.
Semaglutide and tirzepatide carry a boxed warning for thyroid C-cell tumors, based on rodent studies, and are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Other risks your physician screens for include pancreatitis, gallbladder problems and dehydration from GI side effects.
Some people notice hair shedding a few months into treatment. The likely mechanism is telogen effluvium, a temporary, all-over shedding that can follow rapid weight loss or other physical stress and typically starts about three to four months after the trigger (Malkud, 2015). It is usually temporary, but it is worth raising with your physician, because low iron, thyroid problems and too little protein can cause or worsen it and are worth checking.
Less common but more serious considerations exist, which is why screening, monitoring, and an ongoing relationship with your clinical team are essential. Your physician should review your full history, watch for warning signs, and adjust the plan as your body responds.
This article is educational and not medical advice. GLP-1 medications are prescription treatments, and their suitability should always be determined by a qualified provider who knows your individual health picture.
Brand vs Compounded
Brand-name vs compounded GLP-1s
Brand-name GLP-1s such as Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management and were the medications studied in the trials above. Compounded semaglutide and tirzepatide are prepared by pharmacies and are not FDA-approved, which means the FDA has not reviewed them for safety, effectiveness or manufacturing quality, they are not the same as the brand-name products, and they were not studied in those trials.
If you are considering either, ask where the medication comes from, whether the pharmacy is state-licensed, and who is monitoring you. Our guide to compounded vs brand-name GLP-1s goes through the differences in more detail.
Pills vs Injections
GLP-1 pills vs injections for weight loss
Most GLP-1 medications for weight loss are once-weekly injections given with a small pen under the skin. Oral semaglutide has been available as a daily tablet for type 2 diabetes since 2019, and oral options for weight management are newer and still evolving.
A pill is not automatically easier. Oral semaglutide has to be taken on an empty stomach with a small sip of water, then nothing else for a set time, every day. Many people find a weekly injection simpler. Which form is available and appropriate for you, and what your plan covers, is a question for your clinician.
Boosters
Are GLP-1 boosters and supplements the same as GLP-1 medication?
No. Products sold as “GLP-1 boosters” or “natural GLP-1” supplements are not GLP-1 receptor agonists. They typically contain fiber, probiotics, berberine or plant extracts, and none has been shown in trials to produce weight loss comparable to prescription semaglutide or tirzepatide.
Fiber and protein may modestly increase the body's own GLP-1 release after meals, which is one reason they help with fullness. That is a reasonable part of any diet. It is not a substitute for medication when medication is indicated, and supplements can interact with prescriptions, so tell your physician what you take.
Stopping
What happens when you stop taking a GLP-1?
Most people regain weight after stopping a GLP-1 medication, because the appetite effect ends when the drug does. The STEP 4 trial showed this directly. After 20 weeks on semaglutide, 803 adults were split into two groups: those who continued semaglutide lost a further 7.9% of body weight over the next 48 weeks, while those switched to placebo regained 6.9%.
That does not mean a GLP-1 has to be taken forever by everyone. It means stopping should be planned. Protecting muscle, keeping protein and strength training in place, and agreeing a maintenance or taper plan with your physician all make regain less likely. Plan the exit before you start.
Timeline
How long does it take for a GLP-1 to work?
A GLP-1 takes a few weeks to work on hunger and longer to work on weight, so most people notice less hunger long before the scale moves much. Measurable weight loss builds over months, because the dose is raised gradually and the trials measured their main results at 68 to 72 weeks.
A useful check-in point is around three months on a therapeutic dose. If weight, waist and appetite have not changed by then, your physician may review the dose, side effects, adherence and whether another medication would suit you better. Slow early progress is common and is not, by itself, a sign that the medication has failed.
Heart Health
Do GLP-1s lower heart attack and stroke risk?
Yes, GLP-1s can lower heart attack and stroke risk for some people, based on a large trial of semaglutide in adults with existing heart disease. In the SELECT trial, 17,604 adults aged 45 or older with existing cardiovascular disease, a BMI of 27 or more and no diabetes took semaglutide 2.4 mg weekly or placebo. Over about 40 months of follow-up, the combined rate of cardiovascular death, heart attack or stroke was 6.5% with semaglutide and 8.0% with placebo.
The same trial showed the trade-off: 16.6% of people on semaglutide stopped the drug permanently because of adverse events, compared with 8.2% on placebo. These results apply to the brand-name medication in people who already had heart disease. They are not a reason on their own to start a GLP-1, and they were not studied with compounded versions.
Muscle
Do GLP-1s cause muscle loss?
GLP-1s can cause some muscle loss, because part of the weight lost on any GLP-1 is lean mass rather than fat, as happens with most significant weight loss. Across trials, lean mass made up anywhere from about 15% to 40–60% of the weight lost, and lean mass includes organs and water as well as muscle (Neeland et al., 2024).
The practical answer is to protect muscle deliberately: eat enough protein, do resistance work two to three times a week, and track body composition rather than weight alone. A 2025 joint advisory from four obesity and nutrition societies notes that 1.2–1.6 g of protein per kg a day has been proposed during active weight loss and that prolonged intake at or above 2 g/kg should be avoided (Mozaffarian et al., 2025); about 1.6 g/kg is also where resistance-training studies stopped seeing extra lean-mass gains (Morton et al., 2018). Your physician sets your own target. A SECA body composition scan shows whether the weight coming off is fat or muscle. Our guide to GLP-1 muscle loss covers this in more depth.
Alternatives
What are the alternatives to GLP-1s for weight loss?
The alternatives to GLP-1s for weight loss include a structured nutrition and activity plan, other FDA-approved weight-loss medications, and bariatric surgery. GLP-1 medication is one option, not the only one. A structured nutrition and activity plan remains the foundation, and for some people it is enough on its own. Other FDA-approved weight-loss medications with different mechanisms exist, and bariatric surgery generally produces the largest and most durable weight loss for people with severe obesity who qualify.
Which route makes sense depends on your BMI, health conditions, past attempts, preferences and budget. A physician-led medical weight loss program can compare these honestly, including the option of not using medication at all.
Where to Get It
Where to get a GLP-1 for weight loss safely
Get a GLP-1 for weight loss from a licensed clinician who examines your history, orders labs where appropriate and follows you over time — not from a website that sells a vial after a two-minute form. GLP-1s are prescription medications, and the risks in this category usually come from skipped screening, unclear sourcing and nobody watching the dose.
Before you start anywhere, ask four questions: who is the prescribing clinician, where is the medication made, how often will someone review my progress and side effects, and what is the plan if I want to stop. A good program answers all four without hesitation.
Avoid products sold as “research use only” or without a prescription. They are not regulated for human use, their contents and strength are unknown, and they come with no medical oversight at all. At Protocol Health, GLP-1 care starts with a physician consultation in Scarsdale or by telehealth, and continues with monitoring for as long as you are on treatment.
Our Approach
How Protocol Health delivers GLP-1 care
Protocol Health delivers GLP-1 care through a physician evaluation, appropriate lab work, individualized dosing and ongoing monitoring, in person in Scarsdale and by telehealth. Protocol Health is a family-owned, physician-led clinic in Scarsdale, New York, serving Westchester in person and New York, New Jersey, Connecticut, Florida and California by telehealth. Our GLP-1 care is built on real clinical oversight: a physician evaluation, appropriate lab work, individualized dosing, and ongoing monitoring by a team that knows your history.
We treat weight not as a cosmetic number but as a metabolic and longevity marker. That means we look at the whole picture, body composition, hormones, energy, and cardiovascular health, and build a plan around the person in front of us.
If you're considering GLP-1 medications for weight loss, the best next step is a conversation with a clinician who can tell you whether they may be right for you. Learn more about our medical weight loss program or book an assessment to get started.
FAQ
Frequently Asked Questions
What is the difference between semaglutide and tirzepatide?
Semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors. Tirzepatide produced more average weight loss in the SURMOUNT-5 head-to-head trial; semaglutide has a completed cardiovascular outcomes trial in people with heart disease and no diabetes (SELECT). Which fits you depends on your health profile, tolerance and goals, and is a physician decision.
How quickly do GLP-1 medications work for weight loss?
Doses are typically increased gradually over several weeks to reduce side effects, so weight change tends to be steady rather than immediate. Many patients begin noticing reduced appetite early, while measurable weight loss usually unfolds over months. The pace varies from person to person and is never guaranteed.
Do you regain weight after stopping a GLP-1?
Most people regain weight after stopping, because the appetite effect ends when the drug does. In the STEP 4 trial, people switched from semaglutide to placebo regained 6.9% of body weight over 48 weeks, while those who continued lost a further 7.9%. Plan maintenance or a taper with your physician, and keep protein and strength training in place.
Are GLP-1 medications safe?
For appropriately screened patients under medical supervision, GLP-1 medications are widely used, though they carry potential side effects and are not suitable for everyone. Careful screening, gradual dosing, and ongoing monitoring are essential. This is educational information, not medical advice, and suitability should be determined by a qualified provider.
Which GLP-1 is best for weight loss?
In the SURMOUNT-5 head-to-head trial, tirzepatide produced more average weight loss than semaglutide (20.2% vs 13.7% over 72 weeks). The best choice for you still depends on your history, other conditions and side effects, which is why it is a physician decision.
Are GLP-1 booster supplements as effective as GLP-1 medication?
No. GLP-1 booster supplements are not GLP-1 receptor agonists, and none has trial evidence of weight loss comparable to prescription semaglutide or tirzepatide. Fiber and protein can help with fullness, but they are not a substitute for medication when it is indicated.
Can I get GLP-1 treatment through telehealth?
Yes. Protocol Health serves patients across New York, New Jersey, Connecticut, Florida and California by telehealth as well as in person at our Scarsdale clinic. Telehealth care still includes physician oversight and, where appropriate, lab work, so your treatment remains individualized and monitored.
Do I need lab work before starting a GLP-1?
In most cases, yes. Appropriate laboratory work helps your physician confirm candidacy, screen for contraindications, and establish a baseline to monitor over time. It is a core part of responsible, individualized care rather than an optional extra.
Explore